The Economist Cell and Gene Therapy Summit

We're happy to announce our involvement with this years' Economist Cell and Gene Therapy Summit event in Brussels this April!

Economist logo

Under the stewardship of The Economist editors, this inaugural event on cell and gene therapies convenes leaders and policy decision-makers to accelerate access to transformative products.

Who should attend?

  • Policymakers and regulatory bodies
  • Payers and insurers
  • Investors and venture capitalists
  • Medical practitioners and healthcare providers
  • Non-profits and patient advocacy groups

Attendees will learn how healthcare systems and policies need to evolve before these therapies can become mainstream.

We are happy to announce that CGT Catapult's Director of Access Strategy Panos Kefalas is joining the agenda. On the 25th of April, Panos is participating on the 12:00 pm -12:40 pm CEST Panel discussion: The ends justify the means: how can products advance without compromising their commercial potential?

Get your tickets for the event in the sidebar on this page.